Clinical Genomics joins Rotary to battle bowel cancer

toilet with raised seat,

Australian biotechnology company Clinical Genomics is joining forces with Rotary clubs and districts across Australia in a partnership to support their world class awareness initiative in 2015.

The new arrangement will see uniquely Rotary-branded faecal immunochemical tests (FITs) manufactured by Clinical Genomics being used as part of the Rotary Bowelscan and BowelCare programs in 2015. This product will be available for a limited period in May. Some Rotary areas will continue to use alternative technologies in 2015, however the majority will adopt the new kits in 2016.

Clinical Genomics will also provide testing and reporting services to Rotary customers and their nominated medical practitioner as part of the new arrangement.

The Rotary annual program helps raise community awareness of bowel cancer and provides access to screening test kits to facilitate early diagnosis. The program has helped to successfully detect a large number of bowel cancers that may otherwise not have been found early.

Clinical Genomics CEO Dr Larry LaPointe says he is very pleased to be working collaboratively with Rotary.

“It’s great to be working with such a well-respected Australian organisation,” he says.

“We clearly have a shared passionate interest in reducing the impact of bowel cancer in Australia. By working together we can leverage the very latest cancer screening technology developed here in Australia.

“We will do our best to ensure the success of Rotary’s ground breaking health initiative.”

Chairman of the Rotary National Bowel Scan committee Dr Howard Hope says the partnership is all about making the program as successful and impactful as possible.

“We look forward to working with Clinical Genomics and Australian community pharmacists in 2015 to take the program to the next level and to being able to continue to provide this service to the community,” he says.

“It’s great to be integrating a test into our program that has already earned the confidence of Australian healthcare professionals.”

The test being integrated into the Rotary program in 2015 was developed in Australia by Clinical Genomics and is based on the version currently distributed to Australian healthcare professionals, by Quest Laboratories in the USA and by BioChain in China. Approximately three million faecal immunochemical tests are distributed globally each year by Clinical Genomics.

Previous FebFast 2015 goes beyond the booze
Next Aboriginal communities urged to rethink sugary drink

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.

No Comment

Leave a reply